October 2021

Gendius uses its sophisticated AI platform to power digital health solutions for preventing and managing chronic diseases. The award-winning Intellin® app platform, which allows individuals and their healthcare teams to manage their diabetes more effectively, is the first application of Gendius’ AI platform.

Gendius’ key innovation that its platform uses algorithms developed from 10-year longitudinal datasets. These algorithms enable the Gendius platform to identify an individual’s risk for developing complications, allowing for earlier healthcare and lifestyle interventions.

Sam Beni, Applied AI programme lead, said: “We at Tech Nation are delighted to welcome such a wide range of innovative companies to our third Applied AI cohort, and to support them on their scaling journeys.

“Following the turbulence of 2020 with the global pandemic, the number of Applied AI scaleups focussing on transforming the world of healthcare is a beacon of hope for the coming years, and the breadth of industries that these AI scaleups are disrupting is testament to AI’s power to shape the world we live in.”

To date, Gendius’ Intellin® mobile app has been downloaded over 600,000 times and it has over 50,000 monthly active users. The user app allows people with diabetes to plan ahead by forecasting their risk factors for developing complications, such as chronic kidney disease or diabetic foot ulcer. The user app also works with a web-based dashboard for healthcare professionals, which allows them remotely monitor their patients’ disease management. 

Applied AI is Tech Nation’s first growth programme for Artificial Intelligence to help the UK’s most promising founders who are applying AI in practical areas and creating real-world impact. The cohort for Applied AI 3.0 includes a wide range of tech companies, including areas outside health tech such as data analytics, agritech, foodtech, lawtech, retail tech, energy, proptech, fintech, and femtech.